Natixis Investment Managers International’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-14,935
Closed -$2.29M 232
2022
Q2
$2.29M Buy
14,935
+104
+0.7% +$15.9K 0.05% 111
2022
Q1
$2.4M Buy
+14,831
New +$2.15M 0.04% 113
2018
Q4
Sell
-17,593
Closed -$1.66M 17
2018
Q3
$1.66M Buy
17,593
+748
+4% +$70.9K 0.08% 237
2018
Q2
$1.56M Sell
16,845
-3,994
-19% -$390K 0.09% 172
2018
Q1
$1.97M Buy
+20,839
New +$2.29M 0.14% 98
2017
Q4
Sell
-10,871
Closed -$966K 148
2017
Q3
$966K Sell
10,871
-7,504
-41% -$571K 0.08% 166
2017
Q2
$1.33M Sell
18,375
-1,143
-6% -$76.8K 0.12% 124
2017
Q1
$1.27M Buy
19,518
+810
+4% +$50.9K 0.11% 135
2016
Q4
$1.17M Buy
18,708
+11,268
+151% +$688K 0.11% 130
2016
Q3
$469K Buy
7,440
+2,449
+49% +$159K 0.05% 279
2016
Q2
$309K Sell
4,991
-2,687
-35% -$164K 0.03% 302
2016
Q1
$439K Buy
7,678
+342
+5% +$19.1K 0.05% 202
2015
Q4
$435K Hold
7,336
0.06% 179
2015
Q3
$399K Sell
7,336
-523
-7% -$34K 0.05% 235
2015
Q2
$528K Buy
7,859
+185
+2% +$12.1K 0.07% 182
2015
Q1
$449K Sell
7,674
-3,522
-31% -$213K 0.06% 194
2014
Q4
$733K Buy
+11,196
New +$706K 0.1% 140

Other funds holding ABBV

Natixis Investment Managers International's ABBV Position: Q3 2022 in Review

Natixis Investment Managers International sold out of AbbVie (ABBV) in Q3 2022, closing a stake of 14,935 shares — an estimated $2.29M sold.

Natixis Investment Managers International first reported a position in ABBV in Q4 2014 and held it in 17 quarters. The position peaked at $2.4M in Q1 2022. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • Natixis Investment Managers International reported no remaining AbbVie position as of Q3 2022 after selling out during the quarter.
  • Natixis Investment Managers International sold 14,935 AbbVie shares in Q3 2022, an estimated $2.29M.
  • Natixis Investment Managers International first reported a position in AbbVie in Q4 2014 and held it in 17 quarters.
  • Natixis Investment Managers International's AbbVie position peaked at $2.4M in Q1 2022.
  • 2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Natixis Investment Managers International's 13F filing for Q3 2022, filed 14 Nov 2022.